热门资讯> 正文
TRxADE HEALTH收到纳斯达克关于延迟提交年度报告的通知
2024-04-24 05:26
- TRxADE HEALTH (NASDAQ:MEDS) on Tuesday said it has received a notice from Nasdaq, indicating that because the company had not yet filed its Annual Report on Form 10-K for the 2023 fiscal year, it was not compliant with the requirement for continued listing.
- MEDS +7.69% after hours to $7.0.
- Source: Press Release
More on Trxade Group
- Financial information for Trxade Group
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。